Updated Jul 16, 2026
Swirsky Douglas J has filed 1 SEC Form 4 filing across 1 company in the last 90 days — active on both sides. Lifetime open-market purchases: $64K. Lifetime open-market sales: $8K.
Douglas J. Swirsky is the Chief Financial Officer of MaxCyte, Inc., a company specializing in cell engineering technologies. He has been involved in financial management within the biotechnology sector, contributing to the company's growth and operations.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-19 | MXCT | MAXCYTE, INC. | S — Open-market sale | 10.1K | $0.81 | $8K |
| 2025-08-13 | MXCT | MAXCYTE, INC. | P — Open-market purchase | 50.0K | $1.29 | $64K |
Douglas J. Swirsky is the Chief Financial Officer of MaxCyte, Inc., a company specializing in cell engineering technologies. He has been involved in financial management within the biotechnology sector, contributing to the company's growth and operations.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($64K) and 1 open-market sales ($8K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Swirsky Douglas J profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.